NASDAQ:ABOS | Profit Breakdown | Acumen Pharmaceuticals, Inc.

Complete filed revenue-to-profit bridge showing gross profit, operating income, pre-tax income and net income.

Available history
2020-06-30 to 2026-06-30
Data captured

Historical Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2026-06-30-$32.56M-$32.72M
2026-03-31-$21.15M-$20.74M
2025-12-31-$25.2M-$25.14M
2025-09-30-$26.51M-$26.45M
2025-06-30-$41.75M-$40.95M
2025-03-31-$30.37M-$28.8M
2024-12-31-$39.6M-$37.15M
2024-09-30-$32.27M-$29.77M
2024-06-30-$24.38M-$20.54M
2024-03-31-$17.77M-$14.87M
2023-12-31-$18.49M-$16.5M
2023-09-30-$16.04M-$12.96M
2023-06-30-$13.48M-$11.61M
2023-03-31-$13.14M-$11.31M
2022-12-31-$14.25M-$12.87M
2022-09-30-$11.37M-$10.71M
2022-06-30-$10.41M-$10.15M
2022-03-31-$9.21M-$9.13M
2021-12-31-$8.42M-$8.35M
2021-09-30-$3.94M-$3.9M
2021-06-30-$3.44M-$61.36M
2021-03-31-$3.79M-$27M
2020-12-31-$1.34M-$755,000.00
2020-09-30-$2.49M-$2.49M
2020-06-30-$2.04M-$2.04M

Annual Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2025-12-31-$123.83M-$121.34M
2024-12-31-$114.02M-$102.33M
2023-12-31-$61.14M-$52.37M
2022-12-31-$45.24M-$42.86M
2021-12-31-$19.58M-$100.61M
2020-12-31-$7.91M-$7.33M